| Revenue | NOK 1,9B | +2% |
| EBITDA | NOK 333,4M | +10% |
| Net profit | NOK 263,5M | +49% |
| Total assets | NOK 795,3M | +26% |
| Equity | NOK 432,9M | +81% |
| Employees | 633 | — |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 154 620 | 1 319 605 | 1 561 744 | 1 820 436 | 1 852 109 |
| Staff expenses | −324 879 | −344 986 | −387 135 | −429 315 | −424 912 |
| EBITDA | 110 727 | 133 778 | 223 746 | 302 685 | 333 445 |
| Depreciation & amort. | −78 837 | −79 635 | −82 283 | −86 500 | −79 662 |
| EBIT | 31 890 | 54 143 | 141 463 | 216 185 | 253 783 |
| Net financials | −1 942 | 2 536 | 10 992 | 19 699 | 9 711 |
| Profit before tax | 29 949 | 56 679 | 152 455 | 235 884 | 263 494 |
| Tax | 12 434 | 18 895 | 47 938 | 58 889 | −0 |
| Net profit | 17 515 | 37 784 | 104 517 | 176 995 | 263 494 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 731 672 | 810 461 | 946 129 | 630 830 | 795 318 |
| Equity | 431 725 | 467 300 | 566 460 | 239 520 | 432 913 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 261 471 | 297 115 | 339 645 | 391 310 | 362 406 |
| Total debt | 261 471 | 297 115 | 339 645 | 391 310 | 362 406 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AT Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Aleris Healthcare Ab | Company | 100% | 100% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Anita Tunold | Chief Executive Officer | 0 companies |
| Arvid Austgulen | Board of Directors | 0 companies |
| Cecilie Galtung Gundersen | Board of Directors | 0 companies |
| Tomas Øen | Chairman | 0 companies |